USD/JPY, FTSE 100 Forecast: 2 Trades to Watch

Markets are awaiting the Fed decision, with rates widely expected to stay unchanged and USD/JPY holding near 160 as intervention risk rises. Elevated oil prices above $110 a barrel and persistent Middle East tensions are adding inflation pressure and supporting a higher-for-longer rate backdrop. In the UK, the FTSE 100 slipped to a four-week low ahead of the FOMC and BoE meetings, while Lloyds, AstraZeneca, and GSK delivered generally solid Q1 results.

Analysis

The cleanest implication is not the headline rate decision itself, but the interaction between sticky energy, a still-firm dollar, and a central bank that cannot credibly sound dovish without weakening financial conditions. That mix usually supports large-cap defensives and banks with pricing power, while punishing domestic cyclicals and rate-sensitive balance sheets. In the UK, the earnings dispersion matters more than the index move: lenders and pharma can still print, but the broader market is vulnerable if oil keeps compressing consumers and small businesses over the next 1-2 quarters.

For AZN and GSK, the near-term read-through is that defensive growth with global revenue exposure should continue to outperform if macro volatility rises. Their guidance resilience becomes more valuable when UK rate expectations stay sticky and regional growth downgrades accumulate; in that regime, investors pay up for earnings visibility and geographic diversification. LYG is more nuanced: the headline beat is helpful, but the bigger issue is whether credit provisioning becomes a second-half 2025 story as higher energy and weaker UK demand filter into unemployment and arrears.

USD/JPY near 160 remains a trapdoor setup: the market is pricing persistence, but the left-tail is policy intervention rather than gradual mean reversion. If the Fed sounds even modestly less restrictive, the move can unwind fast because positioning around 160 is crowded and the BOJ has already signaled discomfort; that creates a convex, event-driven downside risk in the dollar-yen cross over days, not months. The contrarian view is that equities may be overpricing a benign earnings season: if oil stays elevated, margin pressure and guidance cuts can show up first in consumer-facing UK names and second in credit quality, well before headline macro data deteriorates.

Key Decisions for Investors

• Add to AZN/GSK on a 1-3 week horizon via a relative long: long AZN, short FTSE 100 futures or short a UK domestic cyclical basket. Risk/reward favors defensive global earners if oil remains elevated and BoE stays on hold.
• Fade USD/JPY strength with a tight-risk structure: buy 1-2 month 158/154 put spreads. The payoff is asymmetric because intervention risk increases sharply above 160, while downside can accelerate quickly if Powell sounds less hawkish.
• Take profits or reduce LYG into strength over the next 2-4 weeks. The beat is supportive, but higher provisioning risk and UK macro sensitivity make it less attractive than the pharma defensives on a risk-adjusted basis.
• Pair trade: long AZN, short LYG for 1-2 months. This captures the divergence between durable global pricing power and a lender exposed to a stagflationary UK demand shock.
• If FTSE 100 breaks below the 10,250 area, use that as a trigger to short the index for a move toward 10,000. The risk/reward improves materially only after support fails; otherwise the market is still range-bound.